Stocks
Maze Therapeutics, Inc.MAZE
NASDAQHealthcareBiotechnology$31.95
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing therapies for rare genetic diseases, with a lead program targeting Pompe disease and a proprietary gene regulation platform. Investors track the company for its pipeline catalysts, including upcoming clinical data readouts and regulatory milestones.
52W Range: $21.95-$53.65
Congressional Interest in Maze Therapeutics, Inc. (MAZE)
No congressional trades have been disclosed for Maze Therapeutics, Inc. (MAZE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MAZE?
No congressional trades found for this stock.